drugset / Trial / NCT00180960

Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia

NCT00180960 ↗

Phase 2 Terminated 100 enrolled Gustave Roussy, Cancer Campus, Grand Paris
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the treatment of a cancerous disease of the peritoneum with complete cytoreductive surgery with intraperitoneal chemohyperthermia using oxaliplatin plus irinotecan. This is a Phase II study with 100 patients. Origins of the tumors: these include colon, rectum, appendix, peritoneum, and endocrine tumors.

Timeline

Start
2003-06
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Irinotecan Small molecule — —
Subject Oxaliplatin Small molecule — —